Latest Neutralizing antibody Stories
A researcher at MIT's Koch Institute for Integrative Cancer research has identified a gene that controls the process by which antibodies gain their ability to combat retroviruses.
The pandemic still rages as 33.4 million people worldwide live with the human immunodeficiency virus (HIV).
The human body can produce powerful antibodies that shield cells in the laboratory against infection by an array of HIV strains.
Researchers at Duke University Medical Center, Beth Israel Deaconess Medical Center and Harvard Medical School have demonstrated an approach to HIV vaccine design that uses an altered form of HIV's outer coating or envelope protein.
The HIV epidemic is the largest in the world and represents one of the most serious public health problems.
New research shows that protective immunity against HIV can be achieved without the presence of virus neutralizing antibodies in the blood.
New findings are bringing scientists closer to an effective HIV vaccine.
Researchers have been stymied for years over the fact that people infected with the AIDS virus do indeed produce antibodies in response to the pathogen â€“ antibodies that turn out to be ineffective in blocking infection.
New discoveries about the immune defenses of rare HIV patients who produce antibodies that prevent infection suggest a novel direction for designing new vaccines.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.